Vanguard Group Inc Recursion Pharmaceuticals, Inc. Transaction History

Vanguard Group Inc

$5.97 Trillion
Q2 2025

A detailed history of Vanguard Group Inc transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 36,071,178 shares of RXRX stock, worth $170 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

36,071,178

Previous 32,287,977 11.72%

Holding current value

$170 Million

Previous $171 Million 6.86%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	BUY	$3.97 - $5.84 $15 Million - $22.1 Million	3,783,201 Added 11.72%	36,071,178 $183 Million
Q1 2025 May 09, 2025	SELL	$5.29 - $10.87 $9.11 Million - $18.7 Million	-1,722,017 Reduced 5.06%	32,287,977 $171 Million
Q4 2024 Feb 11, 2025	BUY	$5.7 - $8.27 $55.5 Million - $80.5 Million	9,737,196 Added 40.12%	34,009,994 $230 Million
Q3 2024 Nov 13, 2024	BUY	$5.92 - $8.6 $16.1 Million - $23.4 Million	2,716,252 Added 12.6%	24,272,798 $160 Million
Q2 2024 Aug 13, 2024	BUY	$7.35 - $10.05 $40.7 Million - $55.7 Million	5,541,782 Added 34.6%	21,556,546 $162 Million
Q1 2024 May 10, 2024	BUY	$9.13 - $15.52 $3.19 Million - $5.43 Million	349,554 Added 2.23%	16,014,764 $160 Million
Q4 2023 Feb 14, 2024	BUY	$5.09 - $10.79 $806,133 - $1.71 Million	158,376 Added 1.02%	15,665,210 $154 Million
Q3 2023 Nov 14, 2023	BUY	$6.59 - $15.86 $28 Million - $67.4 Million	4,247,002 Added 37.72%	15,506,834 $119 Million
Q2 2023 Aug 14, 2023	BUY	$4.56 - $9.94 $1.49 Million - $3.24 Million	326,248 Added 2.98%	11,259,832 $84.1 Million
Q1 2023 May 15, 2023	BUY	$6.42 - $9.64 $5.63 Million - $8.45 Million	876,221 Added 8.71%	10,933,584 $72.9 Million
Q4 2022 Feb 10, 2023	BUY	$7.16 - $12.7 $12 Million - $21.3 Million	1,676,377 Added 20.0%	10,057,363 $77.5 Million
Q3 2022 Nov 14, 2022	BUY	$7.83 - $13.6 $10.9 Million - $19 Million	1,393,519 Added 19.94%	8,380,986 $89.2 Million
Q2 2022 Aug 12, 2022	BUY	$5.04 - $9.26 $1.9 Million - $3.48 Million	376,090 Added 5.69%	6,987,467 $56.9 Million
Q1 2022 May 13, 2022	BUY	$6.16 - $18.03 $3.06 Million - $8.97 Million	497,504 Added 8.14%	6,611,377 $47.3 Million
Q4 2021 Feb 14, 2022	BUY	$16.14 - $21.86 $54.9 Million - $74.4 Million	3,401,893 Added 125.44%	6,113,873 $105 Million
Q3 2021 Nov 12, 2021	BUY	$19.03 - $41.33 $549,453 - $1.19 Million	28,873 Added 1.08%	2,711,980 $62.4 Million
Q2 2021 Aug 13, 2021	BUY	$18.0 - $37.42 $48.3 Million - $100 Million	2,683,107 New	2,683,107 $97.9 Million

Others Institutions Holding RXRX

# of Institutions

367

Shares Held

288M

Call Options Held

7.76M

Put Options Held

6.19M

View Full List

About RECURSION PHARMACEUTICALS, INC.

Ticker RXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 180,480,000
Market Cap $850M
Description
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...

More about RXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Recursion Pharmaceuticals, Inc. Transaction History